-+ 0.00%
-+ 0.00%
-+ 0.00%

CARIBOU BIOSCIENCES SHARES FALL 38% TO $0.70 AFTER THE BELL; ANNOUNCED DISCONTINUING CAR-T CELL THERAPY PROGRAMS, EVALUATING STRATEGIC ALTERNATIVES, SUBSTANTIAL JOB CUTS

Reuters·10/06/2026 20:34:01

Please log in to view news